Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB26FWRL9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,095
Award facts
- Contract value 100% obligated
- $12,095.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,095.27 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 27, 2025. No set-aside designation was applied to this award, indicating open competition among qualified vendors.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal medical procurement supporting military and veteran healthcare systems. The company's $1 billion prime IDC with DLA Troop Support Medical functions as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Entresto—a heart failure medication—exemplifies the company's role in fulfilling ongoing pharmaceutical needs within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB26FWRL9?
SPE2DB26FWRL9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FWRL9 worth?
The government has obligated $12,095 on SPE2DB26FWRL9.
Is contract SPE2DB26FWRL9 an order under another contract?
Yes. SPE2DB26FWRL9 is a delivery order under SPE2DB24D2018, an indefinite delivery contract.
Was contract SPE2DB26FWRL9 competed?
The extent of competition for SPE2DB26FWRL9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award